Form 4: Hims & Hers Health Director Christiane Pendarvis Reports Stock Transactions
SEC Form 4 Filing
Director Christiane Pendarvis reports acquisition of Hims & Hers Health Class A Common Stock through vesting of Restricted Stock Units.
Summary
- On March 14, 2025, Christiane Pendarvis, a director of Hims & Hers Health, Inc., reported a transaction involving Class A Common Stock.
- The transaction involved the vesting of 15,211 Restricted Stock Units (RSUs), which converted into an equal number of Class A Common Stock shares.
- Following the transaction, Pendarvis directly owns 26,628 shares of Class A Common Stock.
- The RSUs were granted with a vesting schedule of 1/3 on March 15, 2024, 1/3 on March 15, 2025, and 1/3 on March 15, 2026.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions, and does not contain information that would significantly shift investor sentiment.
Positives
- The vesting of RSUs indicates continued service and commitment of the director to the company.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | 1/3 of RSUs vested |
| 03/14/2025 | Transaction Date: 15,211 RSUs vested and converted to Class A Common Stock |
| 03/15/2025 | 1/3 of RSUs vested |
| 03/15/2026 | 1/3 of RSUs vest |
| 03/18/2025 | Date of report filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.